Drug shortage crisis in Sudan in times of COVID-19

Lucero‐Prisno, Don Eliseo; Elhadi, Yasir Ahmed Mohammed; Modber, Mohamed Abdul Kareem Adam; Musa, Mohamed Babiker; Mohammed, Salma Elmukashfi Eltahir; Hassan, Khlood Fathi; Dafallah, Alaa; Xu, Lin; Ahmadi, Attaullah; Adeyemi, Sylvester; Ekpenyong, Aniekan; Adebisi, Yusuff Adebayo

doi:10.1016/j.puhip.2020.100060

Cited by 30 publications

(23 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, since the demand is too high and no current local drug manufacturers to compensate the available gap, the drug shortage continues to be a major issue in some settings. Drug and medicines accessibility, availability and affordability should be the core of any drug management policy [ 4 ]; however, it is unwarranted to consider that in a country with limited local manufacturing. This paper aims at providing the details on current situation of drug supply chain in Rwanda, and the efforts and shortfalls faced in times of COVID-19 pandemic.…”

Section: Introductionmentioning

confidence: 99%

Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges

Uwizeyimana

Hashim

Kabakambira

et al. 2021

J of Pharm Policy and Pract

Self Cite

View full text Add to dashboard Cite

COVID-19 is a threat to health systems around the world and Rwanda is not an exception. The impact of the pandemic is far-reaching and access to health commodities is not spared. Proper drug supply is critical for a robust healthcare system. It determines the extent at which the population are likely to have access to essential medicines and treatments. In Rwanda, the pharmaceutical sector heavily relies on imports. With the emergence of COVID-19 pandemic, the drug supply system was interrupted leaving many stores from small local pharmacies to the big medical stores running out of stock. The reasons were limited importation of goods from abroad, and the panic buying practice among the customers and some institutions when responding to the pandemic. Drug and medicines accessibility, availability and affordability should be the core of any drug management policy. It is with no doubt that, Rwanda has made a tremendous work to mitigate the effect of COVID-19 on the country’s drug supply; however, efforts are still needed to invest in local pharmaceutical production as a way to minimize import expenses in the country. Good policy on drug importation, production and distribution should be enforced to avoid any drug shortage that may be encountered in the Rwandan drug market.

show abstract

Section: Introductionmentioning

confidence: 99%

Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges

Uwizeyimana

Hashim

Kabakambira

et al. 2021

J of Pharm Policy and Pract

Self Cite

View full text Add to dashboard Cite

show abstract

“…There has also been a parallel growth in local drug manufacturing, coupled with a very high demand of industrial conditions and standards required for both raw materials, dosage form processing, equipment, and processing environment [ 7 , 8 ]. Moreover, the control of global drug business by multinational cooperation that has overcome most of their initial development problems, has resulted in unfair competition from imported products and multinationals against the locally manufactured products [ 9 ].…”

Section: Factors Influencing Drug Shortage In Nigeriamentioning

confidence: 99%

Drug supply shortage in Nigeria during COVID-19: efforts and challenges

Faiva

Hashim

Ramadhan

et al. 2021

J of Pharm Policy and Pract

Self Cite

View full text Add to dashboard Cite

The COVID-19 pandemic has resulted in massive disruptions in global supply chains. Nigeria is particularly vulnerable with respect to pharmaceuticals since there is reduced local production and about 70% of the drug supply is imported creating a huge supply–demand disparity particularly in times like COVID-19. Nigeria is in need of huge quantities of quality-assured health commodities to effectively respond to the pandemic. Significant shortages of other essential medicines and medical products across the country could be imminent. Drug scarcity in Nigeria during the COVID-19 pandemic period is because of several accumulated factors, majorly as a result of global lockdown, decreased manufacturing, unaddressed regulatory affairs, poor access to resources by the population, lack of buffer stocks, security instability, and poor funding of the healthcare system. This situation if left unattended, could cause serious drawbacks to the health of the populace as well as the quality of life of Nigerians amid the COVID-19 Pandemic. Appropriate measures should be directed to ensure ethical processes on drug production, importation, pricing, and distribution to avoid such events during unavoidable scenarios, like the COVID-19 pandemic and other public health emergencies.

show abstract

“…In light of the COVID-19 pandemic, the greatest public health threat of our time, 7 not only the health of African people but also their socioeconomic status and food security have greatly been affected. 8 The pandemic has led to various government-led restrictions and interventions 9 , 10 to curb the spread of the virus on the continent wreaking havoc on the continent’s food supply, and compounding the already bleak picture of food security in Africa. 11 This article aims to highlight Africa’s efforts to mitigate the impact of COVID-19, its implications to food security in Africa, and the recommendations to boost food security amid and after the pandemic in the continent.…”

Section: Introductionmentioning

confidence: 99%

Food Security and COVID-19 in Africa: Implications and Recommendations

Mohamed

Abdallah

Ahmadi

et al. 2021

The American Journal of Tropical Medicine and Hygiene

Self Cite

View full text Add to dashboard Cite

Before the COVID-19 pandemic ravaged Africa, a large percentage of Africans were already affected by poverty and food insecurity. The pandemic wreaked havoc on their already unfavorable situation. The direct and indirect impacts of COVID-19 included but not limited to illness and deaths of food systems’ workers, interruption of food supply chains, unemployment, depreciation of currency value, and disruption of social protection programs. COVID-19 will lead to further economic fallout. Thus, the situation needs careful observation and timely intervention to safeguard the vulnerable African communities. Although Africa has sought ways to lessen the dire impact of the pandemic on food security, short-term solutions should include and enhance social and economic relief initiatives such as monetary intervention and social safety net. Considering a balance between health benefits of COVID-19 restrictions and their economic implications, the African countries, at the regional level, must preserve open and efficient social protection programs and cross-border supply and distribution networks for agricultural inputs. Africa’s medium- and long-term strategies for improving food security should include improving and diversifying its agricultural productivity and production of key food commodities. This will reduce Africa’s dependence on importation of these key commodities, and will help the continent address underlying economic vulnerabilities and better manage food, pandemic, and/or health-related crises affecting food security in the long term.

show abstract

Drug shortage crisis in Sudan in times of COVID-19

Cited by 30 publications

References 12 publications

Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges

Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges

Drug supply shortage in Nigeria during COVID-19: efforts and challenges

Food Security and COVID-19 in Africa: Implications and Recommendations

Contact Info

Product

Resources

About